NRF2 as a Therapeutic Target in Neurodegenerative Diseases

NRF2 как терапевтическая мишень при нейродегенеративных заболеваниях
Nora E. Gray, Mikah S. Brandes
2020-01-01

NRF2NRF2 activatorsneurodegenerative diseasesneuroinflammationoxidative stress
Increased reactive oxygen species production and oxidative stress have been implicated in the pathogenesis of numerous neurodegenerative conditions including among others Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Friedrich’s ataxia, multiple sclerosis, and stroke. The endogenous antioxidant response pathway protects cells from oxidative stress by increasing the expression of cytoprotective enzymes and is regulated by the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2). In addition to regulating the expression of antioxidant genes, NRF2 has also been shown to exert anti-inflammatory effects and modulate both mitochondrial function and biogenesis. This is because mitochondrial dysfunction and neuroinflammation are features of many neurodegenerative diseases as well NRF2 has emerged as a promising therapeutic target. Here, we review evidence for a beneficial role of NRF2 in neurodegenerative conditions and the potential of specific NRF2 activators as therapeutic agents.
1
Because mitochondrial dysfunction and neuroinflammation are common features of neurodegenerative diseases, NRF2 has emerged as a promising therapeutic target.
2
Beyond antioxidant gene regulation, NRF2 exerts anti-inflammatory effects and modulates mitochondrial function and biogenesis.
3
Evidence supporting NRF2’s beneficial role and the therapeutic potential of specific NRF2 activators is reviewed across neurodegenerative conditions.
4
NRF2 regulates endogenous antioxidant responses by inducing cytoprotective enzyme expression, thereby protecting cells from oxidative stress.
5
Oxidative stress and increased reactive oxygen species production are implicated in the pathogenesis of multiple neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s diseases.

NRF2 in neurodegenerative diseases

The therapeutic potential and beneficial effects of NRF2 activation, including antioxidant, anti-inflammatory, and mitochondrial regulatory functions

Publication Details
Publication Date
2020-01-01
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Nora E. Gray
Mikah S. Brandes
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%